CCTC Catalyst Crew Technologies Corp.

NEUTRAL Impact: 4/10 10-K/A
Horizon weeks Filed May 4, 2026 Processed 1mo ago SEC 0001477932-26-002727
Amended annual report (potential restatement)
Latest settled — T+20d
CCTC ▲ +15.79% at T+20d
NEUTRAL call ✓ call won +15.79% · α vs SPY +10.14% · entry $2.09 → $2.42
Next anchor: T+60d in 7w
Currently $2.13 · +1.91% from $2.09 entry
Entry anchored
May 4, 2026
via day open
T+1d
+3.35%
call +3.35% · α +2.55%
$2.16
settled 5w ago
T+5d
+14.83%
call +14.83% · α +11.90%
$2.40
settled 4w ago
T+20d
+15.79%
call +15.79% · α +10.14%
$2.42
settled 8d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Catalyst Crew Technologies Corp. filed Amendment No. 1 to its 2025 10-K to update business description, risk factors, and related-party disclosures following a February 2026 change of control and pivot to an AI healthcare platform. The filing does not restate financials; the company remains development-stage with zero revenue, $29.6M accumulated deficit, and a going concern opinion. The amendment clarifies the new business direction but does not alter the company's precarious financial position.

Actionable Insight

The amendment signals a strategic pivot but does not improve the company's fundamental financial health. Watch for capital raises (equity/debt) to fund the AI healthcare development; any partnership or regulatory milestone could be a catalyst. The stock may remain volatile given penny stock status and low liquidity.

Key Facts

  • Amendment revises Items 1, 1A, 1C, 2, 12, and 13 to reflect change of control and new AI healthcare strategy, but does not modify audited financial statements.
  • Net loss for FY2025 was $207,485, improved from $3,261,038 in FY2024, but revenue remained $0 both years.
  • Accumulated deficit reached $29,600,786 as of Dec 31, 2025; working capital deficit of $630,860; zero cash on hand.
  • Auditor Beckles & Co. issued a going concern opinion; material weaknesses in internal controls exist.
  • On Feb 17, 2026, Kevin Rodan Levy acquired controlling interest (28M shares) and the company acquired AI healthcare assets from Levy for 12M shares; Levy became sole director and CEO.

Financial Impact

No new financial data; existing deficits and going concern status unchanged.

revenuenet lossworking capitalgoing concern

Risk Factors

  • Development-stage with no revenue; may never achieve profitability.
  • Going concern risk; dependent on external financing.
  • Intellectual property acquired from CEO; potential title challenges.
  • Operations in Venezuela carry economic and political risk.
  • Penny stock rules limit liquidity; insider concentration (CEO owns ~71%).

Market Snapshot

Exchange
OTC
Sector
Services-Computer Programming, Data Processing, Etc.

Documents Analyzed

This report is based on 9 SEC documents filed with EDGAR.

DocumentAccession Number
10-K/A Filing (Primary)0001477932-26-002727
Document: cctc_ex312.htm0001477932-26-002727
Document: cctc_ex311.htm0001477932-26-002727
Document: cctc_ex322.htm0001477932-26-002727
Document: cctc_ex321.htm0001477932-26-002727
Document: cctc_ex211.htm0001477932-26-002727
Document: 0001477932-26-002727-index-headers.html0001477932-26-002727
Document: 0001477932-26-002727-index.html0001477932-26-002727
Document: 0001477932-26-002727.txt0001477932-26-002727
3 reports for CCTC
Performance horizon
Filters
Rows
Reports for CCTC — sortable, filterable
Type Now
May 4, 2026
5w ago
10-K/A
NEUTRAL ★ 4/10
$2.09 $2.42▲ +15.79%▲ +10.14%$2.13 (+1.91%)
Apr 13, 2026
8w ago
8-K
MIXED ★ 6/10
$1.54 $2.40▲ +55.84%▲ +49.55%$2.13 (+38.31%)
Apr 8, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$1.40 $2.16▲ +54.29%▲ +45.74%$2.13 (+52.14%)
Showing 3 of 3

US Market Status

Market Open — Closes in 2h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access